Your browser doesn't support javascript.
loading
Immunotherapy with immune checkpoint inhibitors and predictive biomarkers in malignant mesothelioma: Work still in progress.
Perrino, Matteo; De Vincenzo, Fabio; Cordua, Nadia; Borea, Federica; Aliprandi, Marta; Santoro, Armando; Zucali, Paolo Andrea.
Afiliação
  • Perrino M; Department of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Milan, Italy.
  • De Vincenzo F; Department of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Milan, Italy.
  • Cordua N; Department of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Milan, Italy.
  • Borea F; Department of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Milan, Italy.
  • Aliprandi M; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
  • Santoro A; Department of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Milan, Italy.
  • Zucali PA; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Front Immunol ; 14: 1121557, 2023.
Article em En | MEDLINE | ID: mdl-36776840
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mesotelioma Maligno / Neoplasias Pulmonares Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mesotelioma Maligno / Neoplasias Pulmonares Idioma: En Ano de publicação: 2023 Tipo de documento: Article